Morgan Stanley raised the firm’s price target on Sanofi to EUR 108 from EUR 100 and keeps an Equal Weight rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SNY:
- Sanofi says once-weekly Altuviiio approved in Japan
- MacroGenics, Aventis mutually terminate Royalty Purchase Agreement
- Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
- First Wave (NASDAQ:FWBI) Skyrockets on Sanofi Licensing Deal
- First Wave BioPharma licenses Sanofi’s Capeserod for gastrointestinal disorders